| Literature DB >> 23936291 |
Esther M Hoffmann1, Julia Lamparter, Alireza Mirshahi, Heike Elflein, René Hoehn, Christian Wolfram, Katrin Lorenz, Max Adler, Philipp S Wild, Andreas Schulz, Barbara Mathes, Maria Blettner, Norbert Pfeiffer.
Abstract
MAINEntities:
Mesh:
Year: 2013 PMID: 23936291 PMCID: PMC3731336 DOI: 10.1371/journal.pone.0066158
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Prevalence of selected eye parameters, stratified by gender and weighted with the old European standard population.
| Weighted | All | Men | Women |
| Glaucoma | 1.49% | 1.34% | 1.68% |
| Contact lenses | 4.98% | 3.24% | 6.51% |
| Eye drops | 9.68% | 6.79% | 12.43% |
| Relevant eye drops | 1.72% | 1.46% | 2.03% |
| Corneal pathology | 3.74% | 4.59% | 2.96% |
| Relevant corneal pathology | 0.48% | 0.48% | 0.48% |
| Lens status (Pseudophakia) | 1.63% | 1.53% | 1.76% |
| Family history of eye disease | 10.45% | 7.97% | 12.63% |
| Relevant eye disease in family history | 4.61% | 3.79% | 5.58% |
Relative frequencies are shown.
Relevant eye drops: antiglaucomatous eye drops.
Eye drops in general: drops for dry-eye syndrome, general eye care products.
Relevant cornel pathologies: corneal scarring, corneal dystrophies (such as cornea guttata/Fuchs endothelial dystrophy).
Relevant eye disease in family history: history of glaucoma.
Distribution of central corneal thickness in the overall study sample in men and women.
| Weighted | All | Men | Women |
|
| 495, 609 (5th, 95th percentile) | 497, 610 (5th, 95th percentile) | 493, 608 (5th, 95th percentile) |
|
| 498, 616 (5th, 95th percentile) | 503, 618 (5th, 95th percentile) | 496, 616 (5th, 95th percentile) |
|
| 498, 612 (5th, 95th percentile) | 500, 613 (5th, 95th percentile) | 496, 610 (5th, 95th percentile) |
|
| 494, 606 (5th, 95th percentile) | 495, 608 (5th, 95th percentile) | 492, 606 (5th, 95th percentile) |
|
| 1.00, 22.00 (5th, 95th percentile) | 1.00, 23.00 (5th, 95th percentile) | 1.00, 22.00 (5th, 95th percentile) |
Values are weighted with the old European standard population between 35 and 74 years.
Distribution of central corneal thickness in the sample population stratified by age and gender, after weighting procedure.
| Age decades | |||||
| 35–44 | 45–54 | 55–64 | 65–74 | Total | |
| CCTR (N = 4708) |
| ||||
| Men | 558.7 (490.8–626.7) | 552.3 (485.8–618.7) | 555.6 (486.4–624.9) | 553.7 (486.1–621.3) | 555.2 (487.3–623.2) |
| Women | 548.7 (481.1–616.4) | 549.8 (479.7 (619.8) | 549.2 (479. 9–618.4) | 550.8 (478.8–622.8) | 549.5 (480.0–618.9) |
| Total |
|
|
|
|
|
CCTR: Mean central corneal thickness of all right eyes.
CCTL: Mean central corneal thickness of all left eyes.
CCTMean: Mean central corneal thickness between right and left eyes (only analysed when both measurements were available).
CCTMin: The smaller central corneal thickness value between right and left eyes (only analysed when both measurements were available).
CCT Δ: Difference in micrometer between CCT of the right versus left eye (only analysed when both measurements were available).
Figure 1Scatter plots and univariable linear regression of the difference between non-contact applanation tonometry readings versus central corneal thickness in µm in right eyes.
Figure 2Scatter plots and univariable linear regression of the difference between non-contact applanation tonometry readings versus central corneal thickness in µm in left eyes.
Results of multivariate regression analysis (adjusted for gender and age) evaluating the correlation between ophthalmological parameters and central corneal thickness measurements analysed in right and left eyes separately.
| Right Eyes | |||
| R2 | Reg.- coefficient |
| |
|
|
| ||
| Gender | −4.963 |
| |
| Age in years | −0.060 | 0.2417 | |
| Spherical equivalent (right eye) | 0.473 |
| |
| Glaucoma | 3.664 | 0.2571 | |
| Contact lenses, no vs. yes | 0.100 | 0.9717 | |
| Lens status (right eye), phakic vs. pseudophakic | 0.373 | 0.8960 | |
| Iris colour (right eye), light vs. dark | 0.675 | 0.5476 | |
Definition of glaucoma: as disclosed by the participant and/or by the use of antiglaucomatous medication.
Correlation between central corneal thickness and existence of glaucoma as disclosed by the participant and/or use of antiglaucomatous medication, stratified by gender.
| Glaucoma | |||
| Glaucoma | |||
| No | Yes |
| |
|
| |||
| Men | 555.3±34.6 | 551.9±36.5 | 0.51 |
| Women | 549.4±35.4 | 553.4±38.4 | 0.38 |
| Total |
|
|
|
|
| |||
| Men | 559.3±35.0 | 555.4±34.4 | 0.42 |
| Women | 553.5±35.9 | 558.2±39.6 | 0.32 |
| Total |
|
|
|